Beilu Pharmaceutical (300016.SZ) plans to raise no more than 300 million yuan through a simple procedure for private placement.

Zhicheng Finance and Economics APP News, Beilu Pharmaceutical (300016.SZ) disclosed the plan to issue shares to specific investors through a simplified process in 2025. The company plans to issue shares to no more than 35 investors, with the issue price not less than 80% of the average trading price of the company's stock in the twenty trading days before the pricing reference date. The number of shares to be issued will be determined by dividing the total amount of funds raised by the issue price, and will not exceed 30% of the company's total share capital before this issue. The total amount of funds to be raised by issuing shares to specific investors through a simplified process this time is not more than 300 million yuan (including this amount), and the net amount of funds raised after deducting related issuance expenses will be fully invested in the construction of the Land Zhizheng Pharmaceutical Production Workshop and Intelligent Integrated Warehouse Project, the construction of a new 100-ton Iodine Mebromine and 50-ton Iodine Ethanol API production line improvement project, and replenishment of working capital.